[CNBC Television] VIR, GSK begin Phase 3 trial for Covid-19 antibody drug | NEWS – USA Again

[CNBC Television] VIR, GSK begin Phase 3 trial for Covid-19 antibody drug | NEWS – USA Again

Vir Biotechnology and GlaskoSmithKline are expanding their coronavirus antibody drug into Phase 3 trials following positive safety and tolerability data in Phase 2. CNBC’s Meg Tirrell reports.

Click “Read More” to watch on Youtube.

* This website does not store this video. It is embedded from Youtube channel, therefore it is played by Youtube player.